The antiviral polymerase inhibitor against Mucormycosis in silico perspective

Elfiky A. Abdo; Ibrahim N. Mohamed

doi:10.25303/1704rjbt114115

The antiviral polymerase inhibitor against Mucormycosis in silico perspective

Elfiky A. Abdo, Ibrahim N. Mohamed

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

During the emerging second wave of COVID-19 in India in the previous two months, of rare fungal infections the Mucormycosis, was reported and alarmed the possible epidemic of this fungal disease in COVID-19 patients and recovered persons. The total number of reported Mucormycosis infections is high in India as compared to the global reports. The limited oxygen supplies and the rising of the country's death toll during COVID-19 with the highest record of daily new cases attributed to many reasons including the new variant B.1.617 (delta variant) reported in India and 78 other countries.

Original language	English (US)
Pages (from-to)	114-115
Number of pages	2
Journal	Research Journal of Biotechnology
Volume	17
Issue number	4
DOIs	https://doi.org/10.25303/1704rjbt114115
State	Published - Mar 25 2022
Externally published	Yes

Access to Document

10.25303/1704rjbt114115

Cite this

@article{acd63b220d6a43289fa6eec2fe28ec4b,

title = "The antiviral polymerase inhibitor against Mucormycosis in silico perspective",

abstract = "During the emerging second wave of COVID-19 in India in the previous two months, of rare fungal infections the Mucormycosis, was reported and alarmed the possible epidemic of this fungal disease in COVID-19 patients and recovered persons. The total number of reported Mucormycosis infections is high in India as compared to the global reports. The limited oxygen supplies and the rising of the country's death toll during COVID-19 with the highest record of daily new cases attributed to many reasons including the new variant B.1.617 (delta variant) reported in India and 78 other countries.",

author = "Abdo, {Elfiky A.} and Mohamed, {Ibrahim N.}",

note = "KAUST Repository Item: Exported on 2022-06-21 Acknowledgements: Computational support from the King Abdullah University of Science and Technology (KAUST HPC allocation grant “K1482”) and COVID-19 Grant by Cairo University are acknowledged. This publication acknowledges KAUST support, but has no KAUST affiliated authors.",

year = "2022",

month = mar,

day = "25",

doi = "10.25303/1704rjbt114115",

language = "English (US)",

volume = "17",

pages = "114--115",

journal = "Research Journal of Biotechnology",

issn = "2278-4535",

publisher = "World Researchers Associations",

number = "4",

}

TY - JOUR

T1 - The antiviral polymerase inhibitor against Mucormycosis in silico perspective

AU - Abdo, Elfiky A.

AU - Mohamed, Ibrahim N.

N1 - KAUST Repository Item: Exported on 2022-06-21 Acknowledgements: Computational support from the King Abdullah University of Science and Technology (KAUST HPC allocation grant “K1482”) and COVID-19 Grant by Cairo University are acknowledged. This publication acknowledges KAUST support, but has no KAUST affiliated authors.

PY - 2022/3/25

Y1 - 2022/3/25

N2 - During the emerging second wave of COVID-19 in India in the previous two months, of rare fungal infections the Mucormycosis, was reported and alarmed the possible epidemic of this fungal disease in COVID-19 patients and recovered persons. The total number of reported Mucormycosis infections is high in India as compared to the global reports. The limited oxygen supplies and the rising of the country's death toll during COVID-19 with the highest record of daily new cases attributed to many reasons including the new variant B.1.617 (delta variant) reported in India and 78 other countries.

AB - During the emerging second wave of COVID-19 in India in the previous two months, of rare fungal infections the Mucormycosis, was reported and alarmed the possible epidemic of this fungal disease in COVID-19 patients and recovered persons. The total number of reported Mucormycosis infections is high in India as compared to the global reports. The limited oxygen supplies and the rising of the country's death toll during COVID-19 with the highest record of daily new cases attributed to many reasons including the new variant B.1.617 (delta variant) reported in India and 78 other countries.

UR - http://hdl.handle.net/10754/679190

UR - https://worldresearchersassociations.com/Archives/RJBT/Vol(17)2022/April%202022/The%20antiviral%20polymerase%20inhibitor%20against%20Mucormycosis%20in.aspx

UR - http://www.scopus.com/inward/record.url?scp=85131124582&partnerID=8YFLogxK

U2 - 10.25303/1704rjbt114115

DO - 10.25303/1704rjbt114115

M3 - Article

SN - 2278-4535

VL - 17

SP - 114

EP - 115

JO - Research Journal of Biotechnology

JF - Research Journal of Biotechnology

IS - 4

ER -

The antiviral polymerase inhibitor against Mucormycosis in silico perspective

Abstract

Access to Document

Other files and links

Fingerprint

Cite this